Viridian Therapeutics, Inc.\DE Quarterly Return On Assets in % from Q1 2015 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Return On Assets history and growth rate from Q1 2015 to Q4 2024.
  • Viridian Therapeutics, Inc.\DE Return On Assets for the quarter ending December 31, 2024 was -39.6 %, a 35.2% increase year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2024 was -39.6 %, a 35.2% increase from 2023.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2023 was -61.1 %, a 44.4% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2022 was -42.3 %, a 11.4% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -39.6 +21.5 +35.2% Oct 1, 2024 Dec 31, 2024
Q3 2024 -41.5 +16.2 +28.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -44.8 +4.23 +8.62% Apr 1, 2024 Jun 30, 2024
Q1 2024 -48.4 -0.31 -0.64% Jan 1, 2024 Mar 31, 2024
Q4 2023 -61.1 -18.8 -44.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -57.7 -12.4 -27.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -49.1 +1.43 +2.83% Apr 1, 2023 Jun 30, 2023
Q1 2023 -48.1 -0.41 -0.86% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42.3 +5.42 +11.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -45.3 +49.8 +52.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -50.5 +80.5 +61.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -47.7 +104 +68.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -47.7 +139 +74.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -95.2 -6.43 -7.25% Jul 1, 2021 Sep 30, 2021
Q2 2021 -131 -29.8 -29.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -151 -53.6 -54.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -187 -90.2 -93.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -88.7 -8.1 -10% Jul 1, 2020 Sep 30, 2020
Q2 2020 -101 -36.5 -56.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -97.6 -40.8 -71.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -96.9 -54.9 -131% Oct 1, 2019 Dec 31, 2019
Q3 2019 -80.6 -42 -109% Jul 1, 2019 Sep 30, 2019
Q2 2019 -64.7 -26.6 -69.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -56.8 -15.9 -38.8% Jan 1, 2019 Mar 31, 2019
Q4 2018 -42 +9.15 +17.9% Oct 1, 2018 Dec 31, 2018
Q3 2018 -38.6 +19.5 +33.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -38.1 +31.6 +45.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -40.9 +42.3 +50.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -51.1 +81.4 +61.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -58.1 +83.7 +59% Jul 1, 2017 Sep 30, 2017
Q2 2017 -69.7 +42 +37.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 -83.2 +12.3 +12.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -133 -52.4 -65.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -142 -59.8 -72.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -112 -33.5 -42.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -95.5 -6.29 -7.05% Jan 1, 2016 Mar 31, 2016
Q4 2015 -80.1 Oct 1, 2015 Dec 31, 2015
Q3 2015 -82 Jul 1, 2015 Sep 30, 2015
Q2 2015 -78.3 Apr 1, 2015 Jun 30, 2015
Q1 2015 -89.2 Jan 1, 2015 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.